SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-018654
Filing Date
2024-05-30
Accepted
2024-05-30 07:00:35
Documents
15
Period of Report
2024-05-29
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20240530_8k.htm   iXBRL 8-K 32209
2 EXHIBIT 3.1 ex_681330.htm EX-3.1 9839
  Complete submission text file 0001437749-24-018654.txt   197573

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240529.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240529_def.xml EX-101.DEF 13797
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240529_lab.xml EX-101.LAB 18155
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240529_pre.xml EX-101.PRE 13829
18 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240530_8k_htm.xml XML 4817
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 241000676
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)